Macrophage-Mediated Mechanisms in Bone Regeneration

Bone regeneration is orchestrated by the dynamic interplay between immune cells and osteoprogenitor populations. Macrophages, as versatile phagocytes, adopt distinct phenotypes throughout the inflammatory, repair and remodelling phases. During the early inflammatory phase, classically activated macrophages (M1) clear debris and secrete chemokines that recruit mesenchymal stem cells and further immune effectors. A timely transition to alternatively activated macrophages (M2) supports resolution of inflammation, promotes angiogenesis and releases growth factors such as oncostatin M and bone morphogenetic protein 2 to drive osteogenic differentiation. Macrophages also modulate extracellular matrix deposition and vascular ingrowth, thereby shaping the microarchitecture of newly formed bone. Dysregulated macrophage responses—whether due to ageing, persistent inflammation or unfavourable biomaterial properties—can impair healing and lead to non-union. Harnessing macrophage plasticity through immunomodulatory scaffolds and targeted receptor-blockade offers promising, cell-free strategies for orthopaedic and tissue-engineering applications.

Research from Nature Portfolio

Seminal research has delineated how IL-1R1/MyD88 signalling constrains mesenchymal stem cell contributions to bone repair. By inhibiting this pathway, investigators enhanced MSC proliferation, migration and osteogenic commitment via activation of the Akt/GSK-3β/β-catenin cascade. A bespoke MSC delivery system incorporating inhibitors of IL-1R1/MyD88 achieved markedly improved bone formation in vivo, underscoring the potential of innate-receptor modulation to optimise regenerative cell therapies.

Macrophage-Mediated Mechanisms in Bone Regeneration publication trend

The graph below shows the total number of articles in macrophage-mediated mechanisms in bone regeneration across all publications each year (not limited to Nature Index journals).

Technical terms

Macrophage polarization: The process by which macrophages adopt distinct functional phenotypes—M1 (pro-inflammatory) or M2 (anti-inflammatory)—in response to microenvironmental signals.

Mesenchymal stem cells (MSCs): Multipotent stromal cells capable of differentiating into osteoblasts, chondrocytes and adipocytes, and of modulating immune responses through cytokine release.

Matrix metalloproteinases (MMPs): A family of zinc-dependent proteases that remodel extracellular matrix components and regulate growth factor availability during tissue repair.

Oncostatin M (OSM): A cytokine produced by macrophages and other immune cells that enhances osteogenic differentiation of mesenchymal progenitors.

Hydrogel: A three-dimensional polymer network capable of retaining large amounts of water, used as a scaffold for controlled delivery of therapeutic agents and cells in regenerative medicine.

References

1. Matrix Metalloproteinase‐Responsive Hydrogel with On‐Demand Release of Phosphatidylserine Promotes Bone Regeneration Through Immunomodulation. Advanced Science (2024).
2. Modulation of the Inflammatory Response and Bone Healing. Frontiers in Endocrinology (2020).
3. Development of an Accurate and Proactive Immunomodulatory Strategy to Improve Bone Substitute Material-Mediated Osteogenesis and Angiogenesis. Theranostics (2018).
4. Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regeneration. Nature Communications (2016).